Featured News
Trending News
Texas Cardiac Arrhythmia Institute First in U.S. to Implant Leadless Heart Failure Therapy Device
The Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center electrophysiologists have achieved a significant milestone by being the first medical team in the US to implant a novel,…
Saluda Medical Rolls Out EVA Nationwide: A Breakthrough in Spinal Cord Stimulation Treatment
Saluda Medical, Inc., a leader in the advancement of neuromodulation technologies aimed at improving the lives of patients with chronic neurological disorders, has formally declared EVA’s full-scale commercial availability, its…
FDA Grants Orphan Drug Designation to Amphix Bio’s Spinal Cord Injury Treatment
Amphix Bio, an innovative pre-clinical stage biotechnology company, has announced that its lead therapeutic candidate, AMFX-200, has received Orphan Drug Designation from the U.S. Food and Drug Administration for the…
Microcurrent Therapy From Berlin Heals Shows Disease-Modifying Potential in Heart Failure Patients
Berlin Heals, an innovator in the field of bioelectric medicine aimed at treating heart failure, has announced the publication of a groundbreaking peer-reviewed study in the ESC Heart Failure journal….
Novel Artificial Intelligence Models Detect Type 1 Diabetes Risk Before Clinical Onset
Developments from two studies highlighting the potential for machine learning leveraging artificial intelligence (AI) technology to improve early-stage identification of type 1 diabetes were presented as late-breaking poster sessions at…
AllSci Wins Grant to Expand AI Platform for Pharma and Biotech R&D: Accelerating Hypothesis-Driven Discovery
AllSci, a pioneer in AI-driven tools for scientific research, has been awarded a grant from Montgomery County, Maryland’s Technology Innovation Fund – accelerating its mission of making science more accessible, connected, and collaborative. The grant supports…
Nordic Bioscience announces PRO-C3 launched by Roche Diagnostics on cobas analysers
Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used with the ADAPT formula (age, diabetes status, PRO-C3, platelets), assesses liver…
Madhappy Hosts One-Night-Only Fundraiser at Pacific Park in Support of ‘Mental Health Awareness Month
Contemporary lifestyle brand Madhappy will host “Madhappy and Friends,” a one-night-only benefit event at Pacific Park on the Santa Monica Pier on Thursday, May 8 at 6 p.m., in recognition of “Mental Health Awareness Month.” Powered by Shopify, the…
